JANICE RETTIG: Open Payments
NPI 1861772030 · TOLEDO, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$813 in 33 payments from 11 companies in 2025. Trend: 2023 $778 · 2024 $979 · 2025 $813
Food & beverage: $781Education: $32
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 6 | $221 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $150 |
| AstraZeneca Pharmaceuticals LP | 7 | $109 |
| Merck Sharp & Dohme LLC | 5 | $92 |
| BridgeBio Pharma, Inc. | 2 | $60 |
| SCPHARMACEUTICALS INC. | 2 | $55 |
| ABIOMED | 2 | $44 |
| Novo Nordisk Inc | 1 | $32 |
| E.R. Squibb & Sons, L.L.C. | 1 | $20 |
| Novartis Pharmaceuticals Corporation | 1 | $15 |
Products named: Kerendia, AMVUTTRA, ONPATTRO, VERQUVO, Attruby, FARXIGA, FUROSCIX, LOKELMA.
Industry payments across OH — which companies pay providers there.
